Iron polymaltose is a pharmaceutical substance used to treat iron deficiency or iron-deficiency anemia. Suppliers market the medication as 100mg iron polymaltose tablets (either film-coated or chewable) as well as iron polymaltose 10mg/ml oral solutions and 50mg/ml drops.
The drug was first introduced into the market in 1978, and has since then become approved in and supplied to over 80 countries. The largest manufacturers and suppliers of iron polymaltose are Vifor and Sanofi-Aventis. And it is available as both generic and trade name medications.
Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
Retail prices per 30 tablets of iron polymaltose as well as for a 100ml of iron polymaltose 10mg/ml syrup fall into a range of approximately 6-8 EUR.